JOHN N BONFIGLIO
CIK 1222253 · President and COO · last filed 2017-03-13
JOHN N BONFIGLIO is a President and COO who has filed 14 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing, for TPIV, was dated Mar 13, 2017. Across all open-market trades the lifetime net is +$1.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $238.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$238.9K
2
14
$1.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Marker Therapeutics, Inc. (TPIV) Delisted | President and COO | 36,471 | — | — | $0 | 2 | 2017-03-13 |
| OGEN | President and CEO | 385,255 | $0.62 | $238.9K | $1.7K | 3 | 2014-08-13 |
Recent Filings
14 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-03-13 | Marker Therapeutics, Inc. (TPIV) Delisted | Grant (A) | +5,220 | $0 | EDGAR |
| 2016-12-14 | Marker Therapeutics, Inc. (TPIV) Delisted | Mixed | +10,417 | $18.1K | EDGAR |
| 2016-07-19 | — | Grant (A) | +250,000 | $0 | |
| 2015-11-09 | — | Grant (A) | — | $0 | |
| 2014-08-13 | OGEN | Buy (P) | +1,000 | $1.7K | EDGAR |
| 2013-12-02 | OGEN | Mixed | +114,533 | -$180.0K | EDGAR |
| 2013-10-22 | OGEN | Mixed | +100,843 | -$149.5K | EDGAR |
| 2012-10-25 | — | Mixed | +41,543 | -$31.4K | |
| 2012-08-08 | — | Mixed | +97,086 | -$96.0K | |
| 2011-11-16 | — | Grant (A) | +29,000 | $0 |